StockMarketWire.com - Barclays Capital today reaffirms its overweight investment rating on Synthomer [LON:SYNT] and cut its price target to 540p (from 600p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk